Monoclonal anti-body therapy has been used for more than 30 years to treat cancer and infectious diseases, and hospitals have been using it to treat COVID-19 patients with success since the FDA emergency authorization.
“Millions of years of evolution have taught us how to fight a virus, and we’re taking that technology, that ability, that the human body has, and we’re just duplicating it,” said Chief Medical Officer for Palomar Health, Omar Khawaja, MD, MBA.
Normally, when you get a virus your body has an immune response and creates antibodies, but that doesn t happen with COVID-19 as it is a new virus.